(Sonablate, formerly known as SonaCare Medical, LLC), a privately held venture-backed healthcare company, is a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies. Sonablate is committed to developing technologies for urological indications that offer precise and innovative procedures that can control prostate disease and significantly improve quality of life. Sonablate Corpl, with its subsidiaries Focus Surgery, Inc. and UKHIFU, Ltd., designs, manufactures, and service high intensity focused ultrasound (HIFU) surgical ablation systems. Our product, Sonablateยฎ has 501k clearance in the United States for the ablation of prostatic tissue, NMPA approval for prostate cancer in China, and CE Mark. Today, more than 130 Sonablate systems are installed in more than 50 countries. Over 25,000 prostate cancer patients have been treated with Sonablate, which are documented in several peer-reviewed publications spanning 13 years of clinical outcomes.